Patent EP0041089A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0041089A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Improved chromogenic method of detecting endotoxins in blood

Assignee: Whittaker MA Bioproducts Inc
•
Filing: 1980-12-04
•
Granted: —
•
Expires: 2000-12-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved method is provided for detecting endotoxins in blood serum and/or plasma, particularly human blood fractions. The method employs king crab amebocyte lysate, preferably Limulus amebocyte lysate, in the presence of a substrate which has a selected colorimetric indicator bound to it. The indicator is capable of being split from the substrate by an enzyme which can be generated in the lysate by endotoxins in the blood. Thus, the endotoxins convert proenzyme in the lysate to the enzyme which effects the splitting off of the colorimetric indicator from the substrate. The endotoxin concentration in the blood can thus be determined colorimetrically, that concentration being proportional to the concentration of color indicator split from the substrate. The blood sample need not be extracted, as is required in prior methods, with a solvent such as chloroform to remove inhibitors therein which would interfere with a lysate gelation reaction. Heparin is utilized in the present method in a concentration sufficient to stabilize the lysate against loss of potency but insufficientto inhibit the reaction whereby endotoxin generates the described splitting enzyme from proenzyme in the lysate and the reaction of the enzyme to cause the split. The blood fraction need not be diluted with water and the lysate may be one which has been reconstituted from dry powder, if desired. The method is simple, highly effective, reproducible, inexpensive and rapid.

Inventors

  • 👤 Gene Lindsay
  • 👤 Andrew J. O'beirne

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 03:59
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/579; G01N33/52; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/28

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 115 words
An improved chromogenic method of detecting endotoxins in blood, which method comprises:- a. reacting a blood fraction sample which comprises serum and/or plasma with king crab amebocyte lysate and a selected substrate containing a selected colorimetric indicator capable of being split from said substrate by an enzyme, said reaction being carried out for a time sufficient to cause any endotoxin present in the blood fraction to effect the generation in the lysate of enzyme capable of splitting off said colorimetric indicator from said substrate and tq cause said splitting to occur; and b. thereafter determining said endotoxin concentration colorimetrically, said endotoxin concentration being proportional to the concentration of said color indicator split from said substrate.
Claim 2
Dependent Claim 115 words
An improved chromogenic method of detecting endotoxins in blood, which method comprises:- a. reacting a blood fraction sample which comprises serum and/or plasma with king crab amebocyte lysate and a selected substrate containing a selected colorimetric indicator capable of being split from said substrate by an enzyme, said reaction being carried out for a time sufficient to cause any endotoxin present in the blood fraction to effect the generation in the lysate of enzyme capable of splitting off said colorimetric indicator from said substrate and tq cause said splitting to occur; and b. thereafter determining said endotoxin concentration colorimetrically, said endotoxin concentration being proportional to the concentration of said color indicator split from said substrate.
Claim 3
Dependent Claim 24 words
A method according to claim 1 wherein said endotoxin converts proenzyme in said lysate to said enzyme and wherein said blood is human blood.
Claim 4
Dependent Claim 35 words
A method according to claim 2 wherein said lysate is Limulus amebocyte lysate and contains a centration of heparin sufficient to stablize said lysate against loss of potency but insufficient to inhibit said endotoxin-lysate reaction.
Claim 5
Dependent Claim 15 words
A method according to claim 3 wherein said lysate has been reconstituted from dry powder.
Claim 6
Dependent Claim 21 words
A method according to claim 4 wherein said heparin has been added to said lysate after said lysate has been reconstituted.
Claim 7
Dependent Claim 45 words
A method according to claim 2 wherein said blood sample contains a sufficient concentration of blood inhibitors to the gelation reaction which normally occurs between said lysate and endotoxin which may be present in said blood sample so as to substantially inhibit said gelation reaction.
Claim 8
Dependent Claim 15 words
A method according to claim 2 wherein said blood sample is essentially undiluted with water.
Claim 9
Independent Claim 43 words
A method of stabilizing king crab amebocyte lysate against loss of ptency, said method comprising combining with said lysate an amount of heparin sufficient to stablize said lysate against loss of potency but insufficient to inhibit the reaction between said lysate and endotoxins.
Claim 10
Independent Claim 43 words
A method of stabilizing king crab amebocyte lysate against loss of ptency, said method comprising combining with said lysate an amount of heparin sufficient to stablize said lysate against loss of potency but insufficient to inhibit the reaction between said lysate and endotoxins.
Claim 11
Dependent Claim 25 words
A method according to claim 9 wherein said heparin is present in a concentration of at least about 0.1 units per milliter of said lysate.
Claim 12
Dependent Claim 23 words
A method according to claim 9 wherein said heparin is present in a concentration less than 0.8 units per milliter of said lysate.
Claim 13
Dependent Claim 19 words
A method according to claim 10 wherein said heparin concentration is about 0.1-0.4 units per millter of said lysate.
Claim 14
Dependent Claim 18 words
A method according to claim 9 wherein said heparin is in the form of an ammonium salt thereof.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag